NCT01899326 · MORE INFO

Limitations, agreements, and source contact

Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant · Source last updated 2023-03-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: true

limitations And Caveats

description: Target enrollment (n=20) was not reached. The study was stopped during the interim analysis due to low accrual after the widespread use of plerixafor for multiple myeloma in the United States.

point Of Contact

email: amit.verma@einsteinmed.edu
organization: Albert Einstein College of Medicine
phone: 718-430-4091
title: Dr. Amit Verma

Complete source fields

certain Agreement

pi Sponsor Employee: true

limitations And Caveats

description: Target enrollment (n=20) was not reached. The study was stopped during the interim analysis due to low accrual after the widespread use of plerixafor for multiple myeloma in the United States.

point Of Contact

email: amit.verma@einsteinmed.edu
organization: Albert Einstein College of Medicine
phone: 718-430-4091
title: Dr. Amit Verma

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice